Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy.
Siouar Bensaid
,
Amar Kachenoura
,
Nathalie Costet
,
Victor de Ledinghen
,
Julien Vergniol
et al.
Conference proceedings : .. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference , 2016, pp.3602-3605.
⟨10.1109/EMBC.2016.7591507⟩
Journal articles
inserm-01476033v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Jean-Charles Duclos-Vallee
,
Christophe Duvoux
et al.
Hepatology , 2017, 66, pp.873A-874A
Journal articles
hal-01769634v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts
Isabelle Ollivier-Hourmand
,
Yohann Repesse
,
Pierre Nahon
,
Cendrine Chaffaut
,
Thông Dao
et al.
Journal articles
hal-03553907v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Fabien Zoulim
,
Dominique Larrey
et al.
Journal articles
inserm-01057763v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT
Fabien Zoulim
,
Claire Fougerou
,
Roulot Marullo Dominique
,
Sophie Metivier
,
Victor de Ledinghen
et al.
Hepatology , 2022, 76 (Supp 1), pp.S221-S223
Journal articles
hal-03922586v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
Nathalie Ganne-Carrié
,
Cendrine Chaffaut
,
Valérie Bourcier
,
Isabelle Archambeaud
,
Jean-Marc Perarnau
et al.
Journal articles
hal-01880156v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study
Victor de Ledinghen
,
Claire Laforest
,
Christophe Hezode
,
Stanislas Pol
,
Alain Renault
et al.
Journal articles
hal-01743768v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire
,
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
et al.
Journal articles
hal-02648452v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-02648450v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
Jean-Pierre Zarski
,
Nathalie Sturm
,
Jérôme Guechot
,
Adeline Paris
,
Elie-Serge Zafrani
et al.
Journal articles
istex
hal-00866960v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
Sébastien Dharancy
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Christophe Duvoux
,
Nassim Kamar
et al.
Journal articles
hal-01640061v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study
Fabrice Carrat
,
Hélène Fontaine
,
Céline Dorival
,
Mélanie Simony
,
Alpha Diallo
et al.
Journal articles
hal-02050395v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Audrey Coilly
,
Jean-Charles Duclos-Vallee
et al.
Journal articles
hal-02120675v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte Costentin
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-02648451v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort
Aurélie Barrail-Tran
,
Lauriane Goldwirt
,
Thibaut Gelé
,
Claire Laforest
,
Audrey Lavenu
et al.
Journal articles
hal-02280498v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial
Christophe Bureau
,
Dominique Thabut
,
Caroline Jezequel
,
Isabelle Archambeaud
,
Louis D’alteroche
et al.
Journal articles
hal-03229022v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).
Marc Bourlière
,
Jean-Pierre Bronowicki
,
Victor de Ledinghen
,
Christophe Hézode
,
Fabien Zoulim
et al.
Journal articles
hal-01134440v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
Jérôme Boursier
,
Maeva Guillaume
,
Vincent Leroy
,
Marie Irlès
,
Marine Roux
et al.
Journal articles
hal-02416110v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Large-scale screening of lipase acid deficiency in at risk population
Abdellah Tebani
,
Bénédicte Sudrié-Arnaud
,
Hela Boudabous
,
Anais Brassier
,
Rodolphe Anty
et al.
Journal articles
hal-03223991v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort
Hélène Fontaine
,
Claire Fougerou-Leurent
,
Emmanuel Gordien
,
Caroline Scholtès
,
Sophie Métivier
et al.
Journal of Hepatology , 2022, 77, pp.S72-S72
Journal articles
hal-03770282v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
Audrey Coilly
,
Jérôme Dumortier
,
Danielle Botta-Fridlund
,
Marianne Latournerie
,
Vincent Leroy
et al.
Journal articles
hal-01326372v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Dominique Larrey
,
Fabien Zoulim
et al.
Journal articles
hal-01708037v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Journal articles
hal-01807755v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Lucy Meunier
,
Mohamed Belkacemi
,
George Philippe Pageaux
,
Sylvie Radenne
,
Anaïs Vallet-Pichard
et al.
Journal articles
hal-03980202v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte Costentin
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-04075104v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
Georges‐philippe Pageaux
,
Clovis Lusivika Nzinga
,
Nathalie Ganne
,
Didier Samuel
,
Céline Dorival
et al.
Journal articles
hal-03555553v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon
,
Valérie Bourcier
,
Richard Layese
,
Etienne Audureau
,
Carole Cagnot
et al.
Journal articles
hal-01447065v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More